Stockholm, February 22nd, 2016
Karin Bernadotte, board member and primary insider in ContextVision AB, has on February 19th, 2016 purchased 3 500 shares in ContextVision AB at a price of NOK 28,00 per share. Following this transaction, Karin Bernadotte owns 6 500 shares in ContextVision AB.
“The company is in an extremely interesting phase, and I feel very confident about the ongoing research and the future for ContextVision” comments Karin Bernadotte.
This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act.
ContextVision’s cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company’s state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform.
ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.